850081P

Monolyso Heart CA

Avanti Research^™ - A Croda Brand 850081P, powder

• Sinônimo(s): monolysocardiolipin (Heart, Bovine) (sodium salt)
• Número CAS: 383907-65-1
• Código UNSPSC: 12352211
• NACRES: NA.25

Propriedades

• Ensaio: >99% (TLC)
• Formulário: powder
• embalagem: pkg of 1 × 10 mg (850081P-10mg)
• fabricante/nome comercial: Avanti Research^™ - A Croda Brand 850081P
• tipo de lipídio: phosphoglycerides
• Condições de expedição: dry ice
• temperatura de armazenamento: −20°C
• cadeia de caracteres SMILES: O=P([O-])(OC[C@]([H])(O)COC(CCCCCCC/C=C\C/C=C\CCCCC)=O)OCC([H])(O)COP([O-])(OC[C@]([H])(OC(CCCCCCC/C=C\C/C=C\CCCCC)=O)COC(CCCCCCC/C=C\C/C=C\CCCCC)=O)=O.[Na+].[Na+]

Descrição

Descrição geral

Monolysocardiolipin (MLCL) is a class of phospholipid related to cardiolipin. MLCL is a triacylated phospholipid, uncommon in bacterial or eukaryotic membranes. MLCL is prepared from cardiolipin by the hydrolysis action of phospholipase A2 (PLA2).

Aplicação

Monolyso Heart CA is suitable for use:

• as substrate for the synthesis of cardiolipin by the enzyme acyl-CoA:lysocardiolipin acyltransferase (ACLAT1)
• as substrate for the assay of mitochondrial monolysocardiolipin acyltransferase (MLCL AT) activity
• in the preparation of affinity resin MLCL-adriamycin-agarose for the purification of MLCL AT

Ações bioquímicas/fisiológicas

Monolysocardiolipin (MLCL) is a substrate for the biosynthesis of cardiolipin in heart by the activity of MLCL acyltransferase. MLCL is a marker for Barth syndrome. MLCL is implicated in apoptosis.

Embalagem

5 mL Clear Glass Sealed Ampule (850081P-10mg)

Informações legais

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Informações de segurança

• Código de classe de armazenamento: 11 - Combustible Solids
• Classe de risco de água (WGK): WGK 3